@article{8d2abe706258453aa8cb3dae17cca493,
title = "Design, Synthesis, and Biological Evaluation of 4,4{\textquoteright}-Difluorobenzhydrol Carbamates as Selective M1 Antagonists",
keywords = "Drug development, Molecular docking, Muscarinic acetylcholine receptors, Subtype selectivity, DRUG, subtype selectivity, ALLOSTERIC MODULATORS, M1, muscarinic acetylcholine receptors, drug development, MUSCARINIC ACETYLCHOLINE-RECEPTORS, LOGP, molecular docking, LIGANDS, AGONIST",
author = "Jonas Kilian and Marius Ozenil and Marlon Millard and Dorka F{\"u}rt{\"o}s and Verena Maisetschl{\"a}ger and Wolfgang Holzer and Wolfgang Wadsak and Marcus Hacker and Thierry Langer and Verena Pichler",
note = "Funding Information: We sincerely thank M. Mogeritsch for assisting in single-concentration radi-oligand binding experiments, D. Dobusch for HRMS measurements, and J. Wackerlig for co-super-vision of V.M. We kindly acknowledge the Medical Imaging Cluster (MIC). Open Access Funding by the University of Vienna. Publisher Copyright: {\textcopyright} 2022 by the authors. Licensee MDPI, Basel, Switzerland. Copyright: Copyright 2022 Elsevier B.V., All rights reserved.",
year = "2022",
month = feb,
doi = "10.3390/ph15020248",
language = "English",
volume = "15",
journal = "Pharmaceuticals",
publisher = "MDPI AG",
number = "2",
}